Company Profile · Healthcare

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

600329 · Shanghai

Country: China
IPO date: Jun 27, 1997
Employees: 3,890
Website: www.jydrt.com.cn

Buffett Score

73/100

Strong

Financial snapshot

Market capCN¥27.2B

Revenue (TTM)CN¥4.72B

EBITDACN¥1.06B

Profit margin17.96%

ROE11.28%

P/E (TTM)31.82

Forward P/E32.05

PEG0.75

EPSCN¥1.11

Dividend yield13.84%

52-week rangeCN¥33.83 – CN¥50.95

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

About the company

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock

No reports on this stock in your language yet.